Hacohen, Y. Et Al. 2017. Disease course and immunotherapies responses in children with relapsing myelin oligodendrocyte glycoprotein antibodies (MOG-Ab)-associated disease. 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , (Paris, France), 103-104.

Hacohen, Y., Wong, Y. Y., Lechner, C., Jurynczyk, M., Wright, S., Konuskan, B., ... Kalser, J.(2017). Disease course and immunotherapies responses in children with relapsing myelin oligodendrocyte glycoprotein antibodies (MOG-Ab)-associated disease . 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) (pp.103-104). Paris, France

Hacohen, Y. Et Al. "Disease course and immunotherapies responses in children with relapsing myelin oligodendrocyte glycoprotein antibodies (MOG-Ab)-associated disease," 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, France, 2017

Hacohen, Y. Et Al. "Disease course and immunotherapies responses in children with relapsing myelin oligodendrocyte glycoprotein antibodies (MOG-Ab)-associated disease." 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , Paris, France, pp.103-104, 2017

Hacohen, Y. Et Al. (2017) . "Disease course and immunotherapies responses in children with relapsing myelin oligodendrocyte glycoprotein antibodies (MOG-Ab)-associated disease." 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , Paris, France, pp.103-104.

@conferencepaper{conferencepaper, author={Y. Hacohen Et Al. }, title={Disease course and immunotherapies responses in children with relapsing myelin oligodendrocyte glycoprotein antibodies (MOG-Ab)-associated disease}, congress name={7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS)}, city={Paris}, country={France}, year={2017}, pages={103-104} }